Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intervertebral Disc | 26 | 2011 | 123 | 1.860 |
Why?
|
| Bone Morphogenetic Proteins | 18 | 2009 | 69 | 1.230 |
Why?
|
| Proteoglycans | 20 | 2009 | 132 | 1.040 |
Why?
|
| Transforming Growth Factor beta | 10 | 2008 | 87 | 0.880 |
Why?
|
| Extracellular Matrix | 10 | 2009 | 51 | 0.830 |
Why?
|
| Cartilage, Articular | 9 | 2008 | 420 | 0.700 |
Why?
|
| Chondrocytes | 7 | 2009 | 155 | 0.600 |
Why?
|
| Neuroprotective Agents | 2 | 2005 | 55 | 0.450 |
Why?
|
| Fibroblast Growth Factor 2 | 3 | 2008 | 11 | 0.400 |
Why?
|
| Hyaluronic Acid | 3 | 2006 | 56 | 0.320 |
Why?
|
| Animals | 26 | 2011 | 3780 | 0.320 |
Why?
|
| Interleukin-1 | 3 | 2008 | 49 | 0.310 |
Why?
|
| Cattle | 13 | 2009 | 127 | 0.300 |
Why?
|
| Neurosecretory Systems | 1 | 2008 | 9 | 0.300 |
Why?
|
| Cells, Cultured | 13 | 2009 | 539 | 0.290 |
Why?
|
| Bone Morphogenetic Protein 7 | 12 | 2008 | 30 | 0.280 |
Why?
|
| Spinal Diseases | 4 | 2011 | 113 | 0.270 |
Why?
|
| Intervertebral Disc Displacement | 5 | 2011 | 87 | 0.250 |
Why?
|
| Transduction, Genetic | 4 | 2009 | 15 | 0.240 |
Why?
|
| Collagen | 8 | 2009 | 82 | 0.230 |
Why?
|
| Lumbar Vertebrae | 3 | 2009 | 384 | 0.230 |
Why?
|
| Protective Agents | 1 | 2003 | 10 | 0.210 |
Why?
|
| Rabbits | 8 | 2008 | 185 | 0.200 |
Why?
|
| Wound Healing | 1 | 2003 | 159 | 0.190 |
Why?
|
| Keratan Sulfate | 5 | 2009 | 15 | 0.170 |
Why?
|
| Disease Models, Animal | 4 | 2006 | 619 | 0.150 |
Why?
|
| Osteoarthritis | 4 | 2008 | 328 | 0.150 |
Why?
|
| Tissue Engineering | 3 | 2008 | 32 | 0.140 |
Why?
|
| Signal Transduction | 3 | 2008 | 447 | 0.140 |
Why?
|
| High Mobility Group Proteins | 2 | 2007 | 2 | 0.140 |
Why?
|
| Synovial Fluid | 2 | 2008 | 95 | 0.130 |
Why?
|
| Chondroitin ABC Lyase | 2 | 2007 | 4 | 0.130 |
Why?
|
| Cell Transplantation | 3 | 2011 | 23 | 0.130 |
Why?
|
| Transcription Factors | 2 | 2007 | 172 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2008 | 351 | 0.120 |
Why?
|
| Growth Substances | 2 | 2006 | 28 | 0.120 |
Why?
|
| Up-Regulation | 4 | 2008 | 178 | 0.120 |
Why?
|
| Matrix Metalloproteinase 13 | 3 | 2008 | 27 | 0.110 |
Why?
|
| Cell Division | 4 | 2008 | 83 | 0.110 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2008 | 263 | 0.110 |
Why?
|
| Aggrecans | 3 | 2009 | 54 | 0.110 |
Why?
|
| Cell Proliferation | 4 | 2008 | 179 | 0.110 |
Why?
|
| Time Factors | 5 | 2008 | 1491 | 0.100 |
Why?
|
| Bone Regeneration | 2 | 2011 | 74 | 0.100 |
Why?
|
| RNA, Messenger | 4 | 2009 | 308 | 0.100 |
Why?
|
| DNA | 6 | 2009 | 104 | 0.100 |
Why?
|
| In Vitro Techniques | 3 | 2007 | 176 | 0.090 |
Why?
|
| Proteins | 1 | 2011 | 67 | 0.090 |
Why?
|
| NF-kappa B | 2 | 2008 | 118 | 0.090 |
Why?
|
| Cell Culture Techniques | 3 | 2006 | 32 | 0.090 |
Why?
|
| Genetic Therapy | 1 | 2011 | 85 | 0.090 |
Why?
|
| Intervertebral Disc Chemolysis | 2 | 2007 | 6 | 0.090 |
Why?
|
| Biological Products | 1 | 2011 | 45 | 0.090 |
Why?
|
| Extracellular Matrix Proteins | 3 | 2009 | 46 | 0.080 |
Why?
|
| Collagen Type II | 1 | 2009 | 20 | 0.080 |
Why?
|
| Phytoestrogens | 1 | 2008 | 4 | 0.080 |
Why?
|
| Stilbenes | 1 | 2008 | 6 | 0.080 |
Why?
|
| Fruit | 1 | 2008 | 26 | 0.080 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2008 | 2 | 0.080 |
Why?
|
| raf Kinases | 1 | 2008 | 2 | 0.080 |
Why?
|
| Metabolism | 1 | 2008 | 7 | 0.080 |
Why?
|
| Substance P | 1 | 2008 | 12 | 0.080 |
Why?
|
| Matrix Metalloproteinases | 1 | 2008 | 19 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2008 | 33 | 0.080 |
Why?
|
| Interleukin-1beta | 1 | 2008 | 56 | 0.070 |
Why?
|
| Adenoviridae | 4 | 2009 | 17 | 0.070 |
Why?
|
| Corneal Dystrophies, Hereditary | 1 | 2007 | 1 | 0.070 |
Why?
|
| Uniparental Disomy | 1 | 2007 | 1 | 0.070 |
Why?
|
| Sulfotransferases | 1 | 2007 | 5 | 0.070 |
Why?
|
| Thoracic Vertebrae | 1 | 2009 | 92 | 0.070 |
Why?
|
| Cell Survival | 4 | 2008 | 120 | 0.070 |
Why?
|
| Humans | 15 | 2011 | 28435 | 0.070 |
Why?
|
| Hindlimb | 2 | 2004 | 17 | 0.070 |
Why?
|
| Blood Platelets | 1 | 2006 | 39 | 0.060 |
Why?
|
| Lipopolysaccharides | 1 | 2006 | 115 | 0.060 |
Why?
|
| Mutation | 1 | 2007 | 354 | 0.060 |
Why?
|
| Tendons | 1 | 2008 | 224 | 0.060 |
Why?
|
| Ultrasonic Therapy | 1 | 2005 | 24 | 0.060 |
Why?
|
| Fibronectins | 1 | 2005 | 21 | 0.060 |
Why?
|
| Calcitonin | 1 | 2004 | 17 | 0.060 |
Why?
|
| Adult | 5 | 2009 | 8107 | 0.060 |
Why?
|
| SOX9 Transcription Factor | 3 | 2009 | 13 | 0.050 |
Why?
|
| Chymopapain | 1 | 2003 | 5 | 0.050 |
Why?
|
| Genetic Vectors | 3 | 2008 | 60 | 0.050 |
Why?
|
| Viscosity | 1 | 2003 | 9 | 0.050 |
Why?
|
| Acetabulum | 1 | 2005 | 231 | 0.050 |
Why?
|
| Recombinant Proteins | 3 | 2008 | 213 | 0.050 |
Why?
|
| Injections, Intra-Articular | 1 | 2003 | 91 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2008 | 140 | 0.050 |
Why?
|
| Male | 7 | 2009 | 15292 | 0.050 |
Why?
|
| Hip Prosthesis | 2 | 2005 | 552 | 0.040 |
Why?
|
| Aging | 1 | 2009 | 1550 | 0.040 |
Why?
|
| Radiography | 3 | 2006 | 640 | 0.040 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2005 | 821 | 0.040 |
Why?
|
| Gene Expression | 2 | 2008 | 202 | 0.030 |
Why?
|
| Injections, Spinal | 2 | 2007 | 32 | 0.030 |
Why?
|
| Fibromodulin | 2 | 2009 | 3 | 0.030 |
Why?
|
| Decorin | 2 | 2009 | 5 | 0.030 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 2 | 2009 | 9 | 0.030 |
Why?
|
| Biglycan | 2 | 2009 | 5 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2008 | 148 | 0.030 |
Why?
|
| Carrier Proteins | 2 | 2008 | 106 | 0.030 |
Why?
|
| Dogs | 2 | 2005 | 184 | 0.030 |
Why?
|
| Middle Aged | 5 | 2009 | 9270 | 0.030 |
Why?
|
| Lectins, C-Type | 2 | 2004 | 46 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2009 | 4857 | 0.030 |
Why?
|
| Prosthesis Design | 2 | 2005 | 498 | 0.020 |
Why?
|
| Collagen Type X | 1 | 2009 | 3 | 0.020 |
Why?
|
| Lumican | 1 | 2009 | 2 | 0.020 |
Why?
|
| Adolescent | 2 | 2007 | 2309 | 0.020 |
Why?
|
| Vitis | 1 | 2008 | 1 | 0.020 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 1 | 2008 | 7 | 0.020 |
Why?
|
| DNA Replication | 1 | 2008 | 10 | 0.020 |
Why?
|
| ADAMTS4 Protein | 1 | 2008 | 14 | 0.020 |
Why?
|
| Procollagen N-Endopeptidase | 1 | 2008 | 12 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 34 | 0.020 |
Why?
|
| Female | 4 | 2009 | 15728 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 2008 | 29 | 0.020 |
Why?
|
| ADAM Proteins | 1 | 2008 | 41 | 0.020 |
Why?
|
| Aged | 3 | 2009 | 9278 | 0.020 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2008 | 3 | 0.020 |
Why?
|
| Homeostasis | 1 | 2008 | 67 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2008 | 11 | 0.020 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2008 | 32 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 28 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2008 | 169 | 0.020 |
Why?
|
| Phenotype | 1 | 2009 | 313 | 0.020 |
Why?
|
| Back Pain | 1 | 2008 | 62 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2008 | 120 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2007 | 23 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2007 | 31 | 0.020 |
Why?
|
| Leucine | 1 | 2007 | 11 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2007 | 8 | 0.020 |
Why?
|
| Proline | 1 | 2007 | 10 | 0.020 |
Why?
|
| Cornea | 1 | 2007 | 9 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2007 | 26 | 0.020 |
Why?
|
| Pedigree | 1 | 2007 | 67 | 0.020 |
Why?
|
| Homozygote | 1 | 2007 | 21 | 0.020 |
Why?
|
| Joints | 1 | 2008 | 69 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2007 | 160 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2007 | 120 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2007 | 232 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2007 | 284 | 0.020 |
Why?
|
| Culture Media, Serum-Free | 1 | 2006 | 5 | 0.020 |
Why?
|
| Swine, Miniature | 1 | 2006 | 7 | 0.020 |
Why?
|
| Fetal Blood | 1 | 2006 | 13 | 0.020 |
Why?
|
| Genotype | 1 | 2007 | 359 | 0.020 |
Why?
|
| Autoantigens | 1 | 2006 | 25 | 0.020 |
Why?
|
| Swine | 1 | 2006 | 81 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2005 | 16 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2005 | 28 | 0.020 |
Why?
|
| Coccyx | 1 | 2005 | 1 | 0.020 |
Why?
|
| Reference Values | 1 | 2006 | 194 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2005 | 46 | 0.020 |
Why?
|
| Porosity | 1 | 2005 | 61 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2005 | 79 | 0.020 |
Why?
|
| Hexuronic Acids | 1 | 2005 | 6 | 0.020 |
Why?
|
| Glucuronic Acid | 1 | 2005 | 6 | 0.020 |
Why?
|
| Alginates | 1 | 2005 | 7 | 0.020 |
Why?
|
| Glycosaminoglycans | 1 | 2005 | 20 | 0.020 |
Why?
|
| Tail | 1 | 2005 | 1 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2005 | 20 | 0.020 |
Why?
|
| Metacarpophalangeal Joint | 1 | 2005 | 6 | 0.020 |
Why?
|
| Chromium Alloys | 1 | 2005 | 49 | 0.020 |
Why?
|
| Wounds, Stab | 1 | 2005 | 2 | 0.020 |
Why?
|
| Injections | 1 | 2005 | 44 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2004 | 5 | 0.010 |
Why?
|
| Water | 1 | 2005 | 32 | 0.010 |
Why?
|
| Arthrography | 1 | 2005 | 29 | 0.010 |
Why?
|
| Biocompatible Materials | 1 | 2005 | 95 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2005 | 77 | 0.010 |
Why?
|
| Needles | 1 | 2005 | 21 | 0.010 |
Why?
|
| Biolistics | 1 | 2003 | 1 | 0.010 |
Why?
|
| Regeneration | 1 | 2003 | 21 | 0.010 |
Why?
|
| Anterior Cruciate Ligament | 1 | 2004 | 183 | 0.010 |
Why?
|
| Versicans | 1 | 2002 | 7 | 0.010 |
Why?
|
| Amino Acids | 1 | 2002 | 17 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2005 | 737 | 0.010 |
Why?
|
| Age Factors | 1 | 2005 | 781 | 0.010 |
Why?
|
| Osteocalcin | 1 | 2002 | 27 | 0.010 |
Why?
|
| Lumbosacral Region | 1 | 2002 | 59 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2011 | 3616 | 0.010 |
Why?
|
| Low Back Pain | 1 | 2003 | 110 | 0.010 |
Why?
|
| Alloys | 1 | 2002 | 99 | 0.010 |
Why?
|
| Bone Resorption | 1 | 2002 | 85 | 0.010 |
Why?
|
| Osteogenesis | 1 | 2002 | 110 | 0.010 |
Why?
|
| Cobalt | 1 | 2002 | 113 | 0.010 |
Why?
|
| Titanium | 1 | 2002 | 181 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2005 | 988 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2002 | 594 | 0.010 |
Why?
|
| Knee Joint | 1 | 2006 | 746 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2005 | 1859 | 0.010 |
Why?
|
| Disease Progression | 1 | 2002 | 718 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2005 | 1143 | 0.010 |
Why?
|
| Biomarkers | 1 | 2002 | 596 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2002 | 1809 | 0.010 |
Why?
|